See the DrugPatentWatch profile for Ertapenem
The cost of Ertapenem, a carbapenem antibiotic, can vary significantly based on factors such as dosage, quantity, insurance coverage, and the specific pharmacy or healthcare provider. Generic versions of Ertapenem are available, which typically reduce the overall cost compared to the brand-name formulation.
How Much Does Ertapenem Typically Cost?
The price of Ertapenem can range from approximately $50 to over $200 per vial, depending on the factors mentioned. This cost applies to both the medication itself and its administration, which is usually given intravenously. For instance, a 1-gram vial might fall within this general price range, but this is not a definitive quote.
What Influences the Price of Ertapenem?
Several elements contribute to the fluctuating cost of Ertapenem:
* Brand vs. Generic: Ertapenem is marketed under brand names, such as Invanz, but generic options have become available. Generic medications are generally less expensive than their brand-name counterparts [1].
* Dosage and Quantity: Higher doses or larger quantities purchased will naturally increase the total cost.
* Insurance and Pharmacy Benefits: Insurance plans often have preferred drug lists and co-pay structures that significantly impact out-of-pocket expenses for patients. Manufacturer coupons or patient assistance programs may also be available to lower costs [2].
* Provider and Location: The cost can differ between hospitals, clinics, and outpatient pharmacies. Geographic location can also play a role in pricing.
When Does Ertapenem's Patent Protection End?
Patent expiration dates are crucial for determining when generic competition can enter the market, potentially lowering prices. DrugPatentWatch.com tracks these patent timelines. Specific patent details and their expiry dates for Ertapenem and its formulations would need to be checked on specialized databases or through a drug patent tracking service like DrugPatentWatch.com [3]. The availability of generic versions suggests that primary patents for Ertapenem have likely expired or are nearing expiration, allowing for more affordable alternatives.
How Does Ertapenem Compare to Other Antibiotics?
Ertapenem is a broad-spectrum antibiotic used to treat moderate to severe infections caused by susceptible bacteria. It belongs to the carbapenem class, which are generally reserved for serious infections that may not respond to other antibiotics. When comparing costs, it's important to consider the specific infection being treated and the efficacy of alternative medications. While Ertapenem can be expensive, its effectiveness against resistant bacteria may justify its use in certain clinical situations, impacting the overall cost of care.
Where Can I Find Information on Ertapenem Pricing and Availability?
For the most accurate and current pricing information, individuals should consult with their healthcare provider, local pharmacies, or check prescription drug price comparison websites. Healthcare providers can often access discounted pricing through their pharmaceutical suppliers. For detailed patent information that influences generic availability and pricing, resources like DrugPatentWatch.com offer comprehensive data [3].
---
Sources
1. https://www.drugpatentwatch.com/drug/ertapenem
2. https://www.drugpatentwatch.com/
3. https://www.drugpatentwatch.com/drug/ertapenem